{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:29:54Z","timestamp":1792801794801,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Wuhan Municipal Health Commission","award":["No.WX21Q08"],"award-info":[{"award-number":["No.WX21Q08"]}],"id":[{"id":"https:\/\/ror.org\/04jjn5s14","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Wuhan Pharmaceutical Association","award":["No.WHPA202301019"],"award-info":[{"award-number":["No.WHPA202301019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00858-7","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T11:31:58Z","timestamp":1738236718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["An exploratory study evaluating the 20 medications most commonly associated with suicidal ideation and self-injurious behavior in the FAERS database"],"prefix":"10.1186","volume":"26","author":[{"given":"Wen-long","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-chun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-lan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-ping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"1","key":"858_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mcna.2022.03.008","volume":"107","author":"L Sher","year":"2023","unstructured":"Sher L, Oquendo MA. Suicide: an overview for clinicians. Med Clin North Am. 2023;107(1):119\u201330. https:\/\/doi.org\/10.1016\/j.mcna.2022.03.008.","journal-title":"Med Clin North Am"},{"issue":"10024","key":"858_CR2","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/S0140-6736(15)00234-2","volume":"387","author":"G Turecki","year":"2016","unstructured":"Turecki G, Brent DA. Suicide and suicidal behaviour. Lancet. 2016;387(10024):1227\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(15)00234-2.","journal-title":"Lancet"},{"issue":"6","key":"858_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2165\/00023210-200721060-00003","volume":"21","author":"DM Reith","year":"2007","unstructured":"Reith DM, Edmonds L. Assessing the role of drugs in suicidal ideation and suicidality. CNS Drugs. 2007;21(6):463\u201372. https:\/\/doi.org\/10.2165\/00023210-200721060-00003.","journal-title":"CNS Drugs"},{"issue":"3","key":"858_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/wps.20460","volume":"16","author":"P Courtet","year":"2017","unstructured":"Courtet P, Lopez-Castroman J. Antidepressants and suicide risk in depression. World Psychiatry. 2017;16(3):317\u20138. https:\/\/doi.org\/10.1002\/wps.20460.","journal-title":"World Psychiatry"},{"key":"858_CR5","doi-asserted-by":"publisher","first-page":"880496","DOI":"10.3389\/fpsyt.2022.880496","volume":"13","author":"K Li","year":"2022","unstructured":"Li K, Zhou G, Xiao Y, et al. Risk of suicidal behaviors and antidepressant exposure among children and adolescents: a Meta-analysis of Observational studies. Front Psychiatry. 2022;13:880496. https:\/\/doi.org\/10.3389\/fpsyt.2022.880496.","journal-title":"Front Psychiatry"},{"issue":"12","key":"858_CR6","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1001\/jamapsychiatry.2013.2105","volume":"70","author":"AS Iltis","year":"2013","unstructured":"Iltis AS, Misra S, Dunn LB, et al. Addressing risks to advance mental health research. JAMA Psychiatry. 2013;70(12):1363\u201371. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.2105.","journal-title":"JAMA Psychiatry"},{"issue":"15","key":"858_CR7","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","volume":"297","author":"JA Bridge","year":"2007","unstructured":"Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297(15):1683\u201396. https:\/\/doi.org\/10.1001\/jama.297.15.1683.","journal-title":"JAMA"},{"issue":"1","key":"858_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/archdischild-2020-320020","volume":"107","author":"R Luxton","year":"2022","unstructured":"Luxton R, Kyriakopoulos M. Depression in children and young people: identification and management NICE guidelines. Arch Dis Child Educ Pract Ed. 2022;107(1):36\u20138. https:\/\/doi.org\/10.1136\/archdischild-2020-320020.","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"858_CR9","unstructured":"Depression in adults: recognition and management. National Institute for Health and Care Excellence: Guidelines, London. 2018."},{"issue":"1\u20133","key":"858_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jad.2013.01.004","volume":"147","author":"K Hawton","year":"2013","unstructured":"Hawton K, Casanas ICC, Haw C, et al. Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord. 2013;147(1\u20133):17\u201328. https:\/\/doi.org\/10.1016\/j.jad.2013.01.004.","journal-title":"J Affect Disord"},{"issue":"12","key":"858_CR11","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/s41386-023-01676-3","volume":"48","author":"T Lagerberg","year":"2023","unstructured":"Lagerberg T, Matthews AA, Zhu N, et al. Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation. Neuropsychopharmacology. 2023;48(12):1760\u20138. https:\/\/doi.org\/10.1038\/s41386-023-01676-3.","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"858_CR12","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1528-1167.2009.02012.x","volume":"50","author":"DC Hesdorffer","year":"2009","unstructured":"Hesdorffer DC, Kanner AM. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia. 2009;50(5):978\u201386. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02012.x.","journal-title":"Epilepsia"},{"issue":"5","key":"858_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/pds.1932","volume":"19","author":"JB Olesen","year":"2010","unstructured":"Olesen JB, Hansen PR, Erdal J, et al. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf. 2010;19(5):518\u201324. https:\/\/doi.org\/10.1002\/pds.1932.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"858_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1741-7015-8-4","volume":"8","author":"AC VanCott","year":"2010","unstructured":"VanCott AC, Cramer JA, Copeland LA, et al. Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med. 2010;8:4. https:\/\/doi.org\/10.1186\/1741-7015-8-4.","journal-title":"BMC Med"},{"issue":"22","key":"858_CR15","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1212\/01.wnl.0000436614.51081.2e","volume":"81","author":"MJ Pugh","year":"2013","unstructured":"Pugh MJ, Hesdorffer D, Wang CP, et al. Temporal trends in new exposure to antiepileptic drug monotherapy and suicide-related behavior. Neurology. 2013;81(22):1900\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000436614.51081.2e.","journal-title":"Neurology"},{"key":"858_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.yebeh.2018.04.012","volume":"84","author":"CB Josephson","year":"2018","unstructured":"Josephson CB, Engbers JDT, Jette N, et al. Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice. Epilepsy Behav. 2018;84:49\u201355. https:\/\/doi.org\/10.1016\/j.yebeh.2018.04.012.","journal-title":"Epilepsy Behav"},{"issue":"6","key":"858_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJMoa0909801","volume":"363","author":"A Arana","year":"2010","unstructured":"Arana A, Wentworth CE, Ayuso-Mateos JL, et al. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med. 2010;363(6):542\u201351. https:\/\/doi.org\/10.1056\/NEJMoa0909801.","journal-title":"N Engl J Med"},{"issue":"3","key":"858_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/cpt.302","volume":"99","author":"R Harpaz","year":"2016","unstructured":"Harpaz R, DuMochel W, Shah NH. Big Data and adverse drug reaction detection. Clin Pharmacol Ther. 2016;99(3):268\u201370. https:\/\/doi.org\/10.1002\/cpt.302.","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"858_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T, Tamon A, Kadoyama K, et al. Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci. 2013;10(7):796\u2013803. https:\/\/doi.org\/10.7150\/ijms.6048.","journal-title":"Int J Med Sci"},{"issue":"2","key":"858_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/14740338.2023.2189235","volume":"22","author":"S Huang","year":"2023","unstructured":"Huang S, Guo Z, Wang M, et al. Ocular adverse events associated with BRAF and MEK inhibitor combination therapy: a pharmacovigilance disproportionality analysis of the FDA adverse event reporting system. Expert Opin Drug Saf. 2023;22(2):175\u201381. https:\/\/doi.org\/10.1080\/14740338.2023.2189235.","journal-title":"Expert Opin Drug Saf"},{"key":"858_CR21","doi-asserted-by":"publisher","first-page":"1288362","DOI":"10.3389\/fphar.2024.1288362","volume":"15","author":"Y Bao","year":"2024","unstructured":"Bao Y, Chen J, Duan L, et al. Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS). Front Pharmacol. 2024;15:1288362. https:\/\/doi.org\/10.3389\/fphar.2024.1288362.","journal-title":"Front Pharmacol"},{"key":"858_CR22","doi-asserted-by":"publisher","first-page":"1255918","DOI":"10.3389\/fphar.2024.1255918","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Xu S, Yu W, et al. Evaluating cardiac disorders associated with triazole antifungal agents based on the US Food and Drug Administration Adverse Event reporting system database. Front Pharmacol. 2024;15:1255918. https:\/\/doi.org\/10.3389\/fphar.2024.1255918.","journal-title":"Front Pharmacol"},{"issue":"1","key":"858_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/2168479013514236","volume":"48","author":"L Huang","year":"2014","unstructured":"Huang L, Guo T, Zalkikar JN, et al. A review of statistical methods for Safety Surveillance. Ther Innov Regul Sci. 2014;48(1):98\u2013108. https:\/\/doi.org\/10.1177\/2168479013514236.","journal-title":"Ther Innov Regul Sci"},{"key":"858_CR24","doi-asserted-by":"publisher","first-page":"b2880","DOI":"10.1136\/bmj.b2880","volume":"339","author":"M Stone","year":"2009","unstructured":"Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880. https:\/\/doi.org\/10.1136\/bmj.b2880.","journal-title":"BMJ"},{"key":"858_CR25","doi-asserted-by":"publisher","first-page":"e49755","DOI":"10.2196\/49755","volume":"10","author":"SM Jeon","year":"2024","unstructured":"Jeon SM, Lim H, Cheon HB, et al. Assessing the labeling information on drugs Associated with suicide risk: systematic review. JMIR Public Health Surveill. 2024;10:e49755. https:\/\/doi.org\/10.2196\/49755.","journal-title":"JMIR Public Health Surveill"},{"issue":"4","key":"858_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41386-021-01179-z","volume":"47","author":"T Lagerberg","year":"2022","unstructured":"Lagerberg T, Fazel S, Sjolander A, et al. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study. Neuropsychopharmacology. 2022;47(4):817\u201323. https:\/\/doi.org\/10.1038\/s41386-021-01179-z.","journal-title":"Neuropsychopharmacology"},{"key":"858_CR27","doi-asserted-by":"publisher","unstructured":"Healy D. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychother Psychosom. 2003 Mar-Apr;72(2):71\u20139. https:\/\/doi.org\/10.1159\/000068691.","DOI":"10.1159\/000068691"},{"issue":"11","key":"858_CR28","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1017\/S0033291718002568","volume":"49","author":"BW Dunlop","year":"2019","unstructured":"Dunlop BW, Polychroniou PE, Rakofsky JJ, et al. Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder. Psychol Med. 2019;49(11):1869\u201378. https:\/\/doi.org\/10.1017\/S0033291718002568.","journal-title":"Psychol Med"},{"issue":"6","key":"858_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/da.22473","volume":"33","author":"J Lopez-Castroman","year":"2016","unstructured":"Lopez-Castroman J, Jaussent I, Gorwood P, et al. Suicidal depressed patients respond Less Well to antidepressants in the short term. Depress Anxiety. 2016;33(6):483\u201394. https:\/\/doi.org\/10.1002\/da.22473.","journal-title":"Depress Anxiety"},{"issue":"10","key":"858_CR30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.euroneuro.2014.07.007","volume":"24","author":"P Courtet","year":"2014","unstructured":"Courtet P, Jaussent I, Lopez-Castroman J, et al. Poor response to antidepressants predicts new suicidal ideas and behavior in depressed outpatients. Eur Neuropsychopharmacol. 2014;24(10):1650\u20138. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.07.007.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"9","key":"858_CR31","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1001\/jamaneurol.2021.2480","volume":"78","author":"P Klein","year":"2021","unstructured":"Klein P, Devinsky O, French J, et al. Suicidality risk of newer antiseizure medications: a Meta-analysis. JAMA Neurol. 2021;78(9):1118\u201327. https:\/\/doi.org\/10.1001\/jamaneurol.2021.2480.","journal-title":"JAMA Neurol"},{"key":"858_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1749-6632.2001.tb05797.x","volume":"932","author":"HY Meltzer","year":"2001","unstructured":"Meltzer HY. Treatment of suicidality in schizophrenia. Ann N Y Acad Sci. 2001;932:44\u201358. https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb05797.x. discussion 58\u201360.","journal-title":"Ann N Y Acad Sci"},{"issue":"4 Suppl","key":"858_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1359786810385490","volume":"24","author":"K Hor","year":"2010","unstructured":"Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol. 2010;24(4 Suppl):81\u201390. https:\/\/doi.org\/10.1177\/1359786810385490.","journal-title":"J Psychopharmacol"},{"issue":"6","key":"858_CR34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1176\/appi.ajp.2015.15050618","volume":"173","author":"J Tiihonen","year":"2016","unstructured":"Tiihonen J, Mittendorfer-Rutz E, Torniainen M, et al. Mortality and cumulative exposure to Antipsychotics, antidepressants, and benzodiazepines in patients with Schizophrenia: an Observational Follow-Up study. Am J Psychiatry. 2016;173(6):600\u20136. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15050618.","journal-title":"Am J Psychiatry"},{"issue":"2\u20133","key":"858_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.schres.2013.09.001","volume":"150","author":"J Reutfors","year":"2013","unstructured":"Reutfors J, Bahmanyar S, Jonsson EG, et al. Medication and suicide risk in schizophrenia: a nested case-control study. Schizophr Res. 2013;150(2\u20133):416\u201320. https:\/\/doi.org\/10.1016\/j.schres.2013.09.001.","journal-title":"Schizophr Res"},{"issue":"1","key":"858_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/schbul\/sbaa111","volume":"47","author":"H Taipale","year":"2021","unstructured":"Taipale H, Lahteenvuo M, Tanskanen A, et al. Comparative effectiveness of antipsychotics for risk of attempted or completed suicide among persons with Schizophrenia. Schizophr Bull. 2021;47(1):23\u201330. https:\/\/doi.org\/10.1093\/schbul\/sbaa111.","journal-title":"Schizophr Bull"},{"key":"858_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2318-9-20","volume":"9","author":"A Carlsten","year":"2009","unstructured":"Carlsten A, Waern M. Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly? BMC Geriatr. 2009;9:20. https:\/\/doi.org\/10.1186\/1471-2318-9-20.","journal-title":"BMC Geriatr"},{"issue":"4","key":"858_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/15563650.2023.2185493","volume":"61","author":"L Ybanez","year":"2023","unstructured":"Ybanez L, Spiller HA, Badeti J, et al. Suspected suicides and suicide attempts involving antipsychotic or sedative-hypnotic medications reported to America\u2019s poison centers, 2000\u20132021. Clin Toxicol (Phila). 2023;61(4):294\u2013304. https:\/\/doi.org\/10.1080\/15563650.2023.2185493.","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"858_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.amepre.2020.02.012","volume":"59","author":"S Goldman-Mellor","year":"2020","unstructured":"Goldman-Mellor S, Olfson M, Lidon-Moyano C, et al. Mortality following nonfatal opioid and Sedative\/Hypnotic drug overdose. Am J Prev Med. 2020;59(1):59\u201367. https:\/\/doi.org\/10.1016\/j.amepre.2020.02.012.","journal-title":"Am J Prev Med"},{"issue":"3","key":"858_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40264-022-01269-x","volume":"46","author":"M Fusaroli","year":"2023","unstructured":"Fusaroli M, Pelletti G, Giunchi V, et al. Deliberate Self-Poisoning: real-time characterization of suicidal habits and toxidromes in the Food and Drug Administration adverse event reporting system. Drug Saf. 2023;46(3):283\u201395. https:\/\/doi.org\/10.1007\/s40264-022-01269-x.","journal-title":"Drug Saf"},{"issue":"6","key":"858_CR41","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.5546\/aap.2021.e610","volume":"119","author":"DS Garay Bobadilla","year":"2021","unstructured":"Garay Bobadilla DS, Nunez JP, Montenegro Urquieta AM, et al. [Insulin\/glucose therapy for the treatment of severe calcium channel blocker poisoning in pediatrics. Case Report] Arch Argent Pediatr. 2021;119(6):e610\u20135. https:\/\/doi.org\/10.5546\/aap.2021.e610.","journal-title":"Case Report] Arch Argent Pediatr"},{"key":"858_CR42","doi-asserted-by":"publisher","first-page":"115831","DOI":"10.1016\/j.jpba.2023.115831","volume":"238","author":"AL Santunione","year":"2024","unstructured":"Santunione AL, Palazzoli F, Verri P, et al. Cardiovascular drugs and suicide death: determination of carvedilol, amlodipine, doxazosin and diltiazem in two fatal cases. J Pharm Biomed Anal. 2024;238:115831. https:\/\/doi.org\/10.1016\/j.jpba.2023.115831.","journal-title":"J Pharm Biomed Anal"},{"issue":"16","key":"858_CR43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.15585\/mmwr.mm7216a3","volume":"72","author":"R Farah","year":"2023","unstructured":"Farah R, Rege SV, Cole RJ, et al. Suspected suicide attempts by self-poisoning among persons aged 10\u201319 years during the COVID-19 pandemic - United States, 2020\u20132022. MMWR Morb Mortal Wkly Rep. 2023;72(16):426\u201330. https:\/\/doi.org\/10.15585\/mmwr.mm7216a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"858_CR44","unstructured":"Kane SP. ClinCalc DrugStats database, version 2024.08. ClinCalc: https:\/\/clincalc.com\/DrugStats. Updated 7 Aug 2024. Accessed 4 Dec 2024."}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00858-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T11:32:06Z","timestamp":1738236726000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00858-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["858"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00858-7","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for the study involvinghumans in accordance with the local legislation and institutionalrequirements. Written informed consent to participate in this study was not required from the participants or the participants\u2019 legal guardians\/next of kin in accordance with the national legislation and the institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}